Shopping Cart
- Remove All
Your shopping cart is currently empty
Antitumor agent-172 (Compound 28) acts as an inhibitor of the β-catenin/BCL9 interaction, featuring an IC50 of 3.92 μM. This compound exhibits high affinity for β-catenin, with a Kd of 82 nM. Furthermore, Antitumor agent-172 activates T cells, enhances antigen presentation, and demonstrates antitumor activity along with favorable pharmacokinetic properties in murine models.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,270 | 3-6 months | |
| 50 mg | $2,980 | 3-6 months | |
| 100 mg | $4,000 | 3-6 months |
| Description | Antitumor agent-172 (Compound 28) acts as an inhibitor of the β-catenin/BCL9 interaction, featuring an IC50 of 3.92 μM. This compound exhibits high affinity for β-catenin, with a Kd of 82 nM. Furthermore, Antitumor agent-172 activates T cells, enhances antigen presentation, and demonstrates antitumor activity along with favorable pharmacokinetic properties in murine models. |
| Molecular Weight | 670.84 |
| Formula | C37H50N8O4 |
| Cas No. | 3027905-74-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.